rare disease clinical trials

R&D

Net Treatment Benefit in rare disease trials: Aligning trial...

Net Treatment Benefit provides a formal framework to integrate multiple prioritised outcomes into a single measure of overall treatment effect.

R&D

Yellow origami boat sailing a different path than a line of white origami boats

Webinar recap: The future of cell and gene therapy in rare d...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them

R&D

On a journey to diverse, inclusive, and more efficient rare ...

Although orphan drugs represent a sizeable portion of new drug approvals,1most rare diseases still lack effective treatment.

Net Treatment Benefit in rare disease trials: Aligning trial...

Webinar recap: The future of cell and gene therapy in rare d...

On a journey to diverse, inclusive, and more efficient rare ...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

rare disease clinical trials

Editor's Picks